"BMO and Immigration.ca are helping newcomers make real financial progress by providing access to critical resources and essential tools to help them establish their financial life in Canada and make a smooth transition to their new home," said Sumit Sarkar, Head, Customer Growth, BMO. Just over 1.3 million new immigrants settled permanently in Canada from 2016 to 2021, the highest number of recent immigrants recorded in a Canadian census.1 The Government of Canada has set a target of welcoming 500,000 immigrants per year by 2025, and in Canada's 2021 Census nearly 1 in 4 people counted were or had been a landed immigrant or permanent resident in Canada, the highest proportion since Confederation and the largest proportion among G7 countries. Newcomers will have access to trusted online resources and educational content to support financial literacy.
Bmo snaps freee how to#
The new partnership supports newcomers by providing them access to BMO's financial tools, including how to build credit history, establishing saving habits, and building long-term wealth on Immigration.ca, a leading source of multi-disciplinary resources in the Canadian immigration industry with more than 1.5 million monthly page views and one million combined followers on social media. The Government of Canada has set a target of welcoming 500,000 immigrants per year by 2025īMO is helping newcomers to Canada make progress and establish their financial life through a new and exclusive partnership with Immigration.ca, a leading immigration and newcomer resource in Canada. Exclusive partnership with Immigration.ca provides learning resources to help newcomers establish their financial life in Canada
Its BeadArray technology combines microscopic beads and a substrate in a proprietary manufacturing process to produce arrays that can perform various assays simultaneously. Its BaseSpace Informatics Suite integrates directly with its sequencing instruments, allowing customers to manage their biological sample and sequencing runs, process and analyze the raw genomic data, and derive results. Its portfolio of integrated sequencing and microarray systems, consumables, and analysis tools is designed to accelerate and simplify genetic analysis. Its GRAIL segment is a healthcare company focused on early detection of multiple cancers. Its Core Illumina segment offers products and services that serve customers in the research, clinical and applied markets, and enable the adoption of a variety of genomic solutions. The Company operates through two segments: Core Illumina and GRAIL. is a provider of sequencing- and array-based solutions for genetic and genomic analysis. Health Care : Life Sciences Tools & Services | Mid Cap Blend Company profile
0 kommentar(er)
